Furthermore, we find that BMAL1 protein is present in a greater proportion of nuclei, and therefore likely to be more active, in ccRCC tumors compared to non-tumor kidney samples and compared to other types of renal cancer (Figs. 1D and S1C). This evidence concerns the gene BMAL1 and nonpapillary renal cell carcinoma.